Device Trial Radar · NCT07663305
Evaluation of a Mobile Menopause Application
Last checked: Nov 19, 2026Latest source record: Oct 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
426
Planned (sponsor's estimate)
Start
Jul 6, 2026
Primary completion
May 2027
Study completion Aug 2027
Sponsor
- Lead sponsor
- Endo Health GmbHNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 23, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (care provider, investigator)
- Primary purpose
- Supportive care
- FDA-regulated device
- No
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study examines whether a digital app can help women manage symptoms of menopause. A total of 426 women with medically confirmed menopausal symptoms are randomly assigned to either use the app in addition to their usual medical care for 24 weeks, or to continue with usual care alone. The app provides evidence-based content and exercises for multimodal menopause management. Participants are followed up over 24 weeks, with the primary outcome assessed at 12 weeks. The main goal is to evaluate whether the app improves menopause-specific quality of life.
Conditions
- N95.1 Menopausal and Female Climacteric States
Interventions
Menopause AppDevice
The menopause app facilitates the implementation of multimodal self-management strategies in the daily routines of individuals with a menopausal disorder, through tools such as a symptom diary and guided interactive exercises.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Menopause-specific quality of lifeTime frame: Changes between time point T0 (baseline) and T3 (12 weeks after baseline)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Medicoles
Hanover, Germany · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.